﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Silicon Investor - NUMD: NuMED Stock of the Month on SmallCap Investor</title><copyright>Copyright © 2026 Knight Sac Media.  All rights reserved.</copyright><link>https://www.siliconinvestor.com/subject.aspx?subjectid=14209</link><description>
Reprinted from: The SmallCap Investor's Stock of the Month - April 1997                                                                                   Posted: March 31, 1997                              NuMED Home Health Care, Inc.                                 Nasdaq SmallCap: NUMD   New Business Breathes New Life into Beleaguered NuMed.   Hardy Home Health Care Company is an Excellent Value for Investors Seeking Turnaround Stocks.   The last ten months have been pretty tough for nascent NuMED Home Health Care, Inc. (Nasdaq SmallCap: NUMD). After nearly three years of double and triple-digit revenue growth and a flattering buy-out offer, NuMED has been besieged by a number of setbacks which have resulted in a harrowing seventy-two percent decline in its stock price from a high of $4.31 per share in June 1996. The events which dominated the "fiscal year from hell" can, perhaps, be described as "bad luck", "bad timing" and even "ironic". Yet many of the forces which decimated shareholder value have come to pass and with in invigorating influx of new business on hand, NuMED may soon prove to be a bargain at today's prices.   Clearwater, Florida based NuMED operates eight wholly-owned subsidiaries providing a broad range of health care related services. These services include comprehensive home health care services, temporary staffing of nursing personnel and long-term staffing of physical therapists, occupational therapists and speech/language pathologists to hospitals, clinics, long-term care facilities, physician offices, etc. NuMED's business is part of a growing market driven by the general aging of the U.S. population, a rising focus on cost effective use of health care dollars and the increased use of treatment at home as an alternative to hospitalization.   Since hospitals receive fixed Medicare reimbursements based upon a patient's diagnosis, regardless of the cost of service or length of stay, there is an incentive is to minimize the length of patients' stays and increase the use of home health services. Additionally, advances in medical technology have enabled more treatments to be provided on an outpatient basis, or in the patient's home, nursing homes, or clinics. The result is a shortage of qualified medical personnel, administrative staff and other related services which NuMed provides. And, until recently, things were going pretty well for NuMED.   Between March 31, 1993 and March 31, 1996, NuMED was able to accomplish a fivefold increase in its revenues due to internal growth and and strategic acquisitions. For the fiscal year ended March 31, 1996, net revenues increased 158% to a record $24.1 million. Net income for the period was a record $0.02 per share. Excluding non-recurring expenses, net income per share would have been $0.06. Cash flow per share for the 1996 fiscal year increased to $0.15. In the optimistic words of NuMED's Chairman and CEO, Jugal K. Taneja, "NuMED turned the critical corner to profitability in fiscal ...</description><image><url>https://www.siliconinvestor.com/images/Logo380x132.png</url><title>SI - NUMD: NuMED Stock of the Month on SmallCap Investor</title><link>https://www.siliconinvestor.com/subject.aspx?subjectid=14209</link><width>380</width><height>132</height></image><ttl>10</ttl></channel></rss>